Don’t Trade in the Dark—Get Your Pre-Market Report Every Day.Join Now
Evexia Lifecare Ltd| Audited Standalone Q4 & FY26 Financial Results
Report Source
⬤9th May 26
Summary : Evexia Lifecare reported increased profits and revenue, but faces severe audit qualifications, including significant credit risks, valuation issues, and going concern doubts for a subsidiary.
Quarterly Report Analysis & Insights
Financial Disclosures
- Standalone FY26 Total Expenses: Rs. 10,429.48 Lakhs (FY25: Rs. 8,281.95 Lakhs).
- Consolidated FY26 Total Expenses: Rs. 10,807.70 Lakhs (FY25: Rs. 8,620.00 Lakhs).
- Significant credit risk identified in loans and trade receivables.
- Standalone FY26 Revenue from operations: Rs. 10,546.47 Lakhs (FY25: Rs. 8,388.68 Lakhs).
- Consolidated FY26 Revenue from operations: Rs. 11,027.50 Lakhs (FY25: Rs. 8,659.04 Lakhs).
- Standalone FY26 Net cash used in operating activities: Rs. (2,288.06) Lakhs (FY25: Rs. (592.78) Lakhs).
- Consolidated FY26 Net cash used in operating activities: Rs. (2,348.34) Lakhs (FY25: Rs. (441.37) Lakhs).
- Standalone FY26 Net cash from investing activities: Rs. 2,192.08 Lakhs (FY25: Rs. (1,451.43) Lakhs).
- Consolidated FY26 Net cash from investing activities: Rs. 5,267.73 Lakhs (FY25: Rs. (1,579.65) Lakhs).
- Standalone FY26 Cash & cash equivalents at year-end: Rs. 9.04 Lakhs (FY25: Rs. 2.92 Lakhs).
- Consolidated FY26 Cash & cash equivalents at year-end: Rs. 237.52 Lakhs (FY25: Rs. 62.41 Lakhs).
- Direct tax litigations and statutory compliance matters.
- Standalone FY26 Total Assets: Rs. 86,430.20 Lakhs (FY25: Rs. 83,440.20 Lakhs).
- Consolidated FY26 Total Assets: Rs. 87,341.88 Lakhs (FY25: Rs. 89,448.13 Lakhs).
- Standalone FY26 Net Worth: Rs. 43,714.10 Lakhs (FY25: Rs. 42,958.05 Lakhs).
- Consolidated FY26 Net Worth: Rs. 43,444.20 Lakhs (FY25: Rs. 45,956.80 Lakhs).
- Consolidated results include unaudited financial statements of six subsidiaries.
Corporate Overview
- India
- Tongo
- Significant credit risk in loans and trade receivables.
- Inability to determine fair valuation for unquoted investments.
- Subsidiary Kavit Edible Oil Limited faces going concern doubt.
- Instances of material misstatements and non-compliance.
- Lifecare and Edible Oil (via subsidiary) operations.
- Management believes tax litigations are contestable.
- Management believes FCCB extension has no material adverse impact.
- Lifecare
- Edible Oil (via subsidiary)
- Kavit Edible Oil Limited suspended manufacturing operations since March 2019.
Risk Factors
- Significant credit risk in loans receivables.
- Significant credit risk in trade receivables.
- Subsidiary faces going concern doubt.
- Material misstatements and missing documentation.
Key Drivers
- Net profit increased significantly year-on-year.
- Revenue from operations showed healthy growth.
- Investing cash flow turned positive.
- Cash and equivalents balance improved.
Auditor’s Report
- Qualified Opinion (Standalone and Consolidated)
- Loans receivables (Rs. 735.13 Lakhs) with significant credit risk, lacking expected credit loss assessment.
- Trade receivables (Rs. 2943.89 Lakhs) with significant credit risk, lacking expected credit loss assessment.
- Investments in unquoted equity shares (Rs. 87.39 Lakhs) with undetermined fair valuation.
- Subsidiary Kavit Edible Oil Limited has suspended operations, negative net worth, raising going concern doubt.
- Material misstatements, non-compliance, improper valuation, and missing documentation.
- Consolidated results include unaudited financial statements of six subsidiaries.
- Direct tax litigations and statutory compliance matters, considered contestable by management.
Board Commentary
- Significant credit risk in loans and trade receivables.
- Subsidiary Kavit Edible Oil Limited faces going concern doubt.
- Involved in direct tax litigations and statutory compliance matters.
- Extended FCCB conversion/redemption period from March 2026 to February 2028.
Corporate Governance
- Audit Committee is in place.
- Repetitive qualified audit opinion.
- Material misstatements and non-compliance with reporting framework.
- Inadequacies in recognition and measurement of provisions.
- Missing documentation and unverified significant transactions.
Management Discussion & Analysis
Future Strategy
- Extended Foreign Currency Convertible Bonds (FCCB) conversion/redemption period to February 2028.
Risk Control Measures
- Management considers direct tax litigations contestable.
- Management believes FCCB extension has no material adverse impact.
Critical Risks
- Significant credit risk in loans receivables (Rs. 735.13 Lakhs).
- Significant credit risk in trade receivables (Rs. 2943.89 Lakhs).
- Inability to fair value unquoted equity investments (Rs. 87.39 Lakhs).
- Subsidiary Kavit Edible Oil Limited has negative net worth and going concern doubt.
- Material misstatements, non-compliance, and missing documentation.